According to Immix Biopharma's latest financial reports the company's current earnings (TTM) are -C$26.83 M. In 2023 the company made an earning of -C$21.34 M a decrease over its 2022 earnings that were of -C$11.15 M.The earnings displayed on this page is the company's Pretax Income.